» Authors » Izumi Kikuchi

Izumi Kikuchi

Explore the profile of Izumi Kikuchi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 126
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujimoto K, Kawasaki Y, Morimoto K, Kikuchi I, Kawana S
J Nippon Med Sch . 2014 Jul; 81(3):157-63. PMID: 24998962
Skin eruption with mild itching of the hands and feet developed in a man in his 90s 1 month after he was hospitalized following a traffic accident. Scabies was diagnosed...
2.
Kikuchi S, Kikuchi I, Takaku Y, Kobayashi T, Hagiwara K, Kanazawa M, et al.
Int Arch Allergy Immunol . 2009 Jun; 149 Suppl 1:87-93. PMID: 19494512
Background: There is evidence that eosinophils and neutrophils are simultaneously increased in the airways of some patients with chronic refractory asthma. The mechanisms by which neutrophils accumulate in the airways...
3.
Ueno T, Kume H, Mitsuishi T, Morimoto K, Kikuchi I, Kawana S
J Dermatol . 2009 Feb; 35(12):778-81. PMID: 19239558
We describe a case of systemic lupus erythematosus (SLE)-associated cutaneous cryptococcosis. A 32-year-old woman with SLE and lupus nephritis presented with the erythematous maculae on the chest and the extremities,...
4.
Kikuchi I, Tanuma H, Morimoto K, Kawana S
Mycoses . 2008 Apr; 51(6):523-31. PMID: 18422915
To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic-type tinea pedis from the pharmacokinetic point of view, 20 patients with hyperkeratotic-type tinea pedis were...
5.
Kikuchi I, Tanuma H, Morimoto K, Kawana S
Mycoses . 2007 Dec; 51(1):7-13. PMID: 18076589
To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic type tinea pedis, from the pharmacokinetic point of view, 20 patients with hyperkeratotic type tinea...
6.
Kikuchi I, Kikuchi S, Kobayashi T, Takaku Y, Hagiwara K, Kanazawa M, et al.
Int Arch Allergy Immunol . 2007 Aug; 143 Suppl 1:44-9. PMID: 17541276
Background: Recent evidence suggests that both neutrophilic and eosinophilic inflammation persist in the airways of patients with severe asthma. Neutrophils can secrete a variety of mediators which may augment the...
7.
Kobayashi T, Takaku Y, Kikuchi I, Soma T, Hagiwara K, Kanazawa M, et al.
Int Arch Allergy Immunol . 2007 Aug; 143 Suppl 1:38-43. PMID: 17541275
Background: There is increasing evidence that both neutrophilic and eosinophilic inflammation persist in the airways of patients with severe asthma. We have reported a positive relationship between the concentrations of...
8.
Terauchi Y, OLeary L, Kikuchi I, Asanagi M, Yoshioka T, Kobayashi C, et al.
J Endod . 2007 Apr; 33(5):585-8. PMID: 17437878
A novel file-removal system (FRS) was designed to address weak points of conventional file-removal methods. The purpose of this study was to compare file-removal time and dentin removal rates among...
9.
Kushiya M, Saito K, Kikuchi I, Kobayashi T, Hagiwara K, Kanazawa M, et al.
Int Arch Allergy Immunol . 2006 Jun; 140 Suppl 1:17-22. PMID: 16772722
Background: Beta2-agonists, a representative class of bronchodilators used for asthma, have been shown to modulate some functions of eosinophils, including cell adhesion. Similarly, a leukotriene receptor antagonist (LTRA) may be...
10.
Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Sakamoto Y, Kanazawa M, et al.
Am J Respir Cell Mol Biol . 2006 Feb; 34(6):760-5. PMID: 16456187
Neutrophilic inflammation observed with severe asthma is often associated with interleukin-8 (IL-8). Neutrophils can secrete a variety of mediators that may augment the migration of eosinophils. We have reported a...